Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$16.6M
2 rounds on record
Latest round
$16.6M
Venture round · Aug 2022 · 4 yr ago
Team
16
US Form 5500 (plan participants) · Apr 2025
Grants
$2M
1 grant · CORDIS
Backers
1
AlleyCorp
The money's age
Long since its last round
50 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025 Team shrank to 16 was 27 · US Form 5500 (plan participants) Sep 5, 2023 Won a grant $2M · CORDIS Aug 10, 2022 Raised a round Venture round $16.6M · SEC Form D 2019 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Sep 2023 $2M — CORDIS
Venture round Aug 2022 $16.6M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Orange Grove Bio LLC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Marc AppelExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Breaking medical barriers through university partnerships to accelerate drug development for treating cancer, autoimmune, and inflammatory diseases.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
AlleyCorpVia a fund
140 portfolio companies: Nosis Biosciences, Syenex, Vibe Bio and 137 more

People

Marc Appel
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cincinnati United States
HQ

Financials

Total raised
$18.6M
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2023 $2M Details
Venture - Series Unknown 2022 $16.6M Details